These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12974441)

  • 1. Antituberculous therapy-induced toxicity.
    Bharat A; Vedkumar M; Subhash HS; Abraham OC; Mathai D
    J Assoc Physicians India; 2003 May; 51():522-4. PubMed ID: 12974441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute respiratory distress syndrome: a manifestation of immune reconstitution in an HIV-negative patient with tuberculosis].
    Wikman PE; Jover F; Peris J; Cuadrado JM
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):132-3. PubMed ID: 19254644
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid induced gynaecomastia: a case report.
    Garg R; Vaibhav ; Mehra S; Prasad R
    Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynaecomastia during antituberculosis chemotherapy with isoniazid.
    Dixit R; Sharma S; Nawal CL
    J Assoc Physicians India; 2008 May; 56():390-1. PubMed ID: 18700651
    [No Abstract]   [Full Text] [Related]  

  • 6. Genitourinary tuberculosis. A study of 1117 cases over a period of 34 years.
    Gow JG; Barbosa S
    Br J Urol; 1984 Oct; 56(5):449-55. PubMed ID: 6534442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of drug therapy in urogenital tuberculosis].
    Jungbluth H
    Urologe A; 1984 Jul; 23(4):189-93. PubMed ID: 6540914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid associated, painful, bilateral gynaecomastia.
    Khanna P; Panjabi C; Maurya V; Shah A
    Indian J Chest Dis Allied Sci; 2003; 45(4):277-9. PubMed ID: 12962465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fulminant hepatitis during the therapy for tuberculous meningitis].
    Garavelli PL
    Recenti Prog Med; 1996 Dec; 87(12):597. PubMed ID: 9102699
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypothermia due to anti-tuberculosis drugs: first case].
    Oualil H; Nejjari S; Bourkadi JE; Iraqi G
    Rev Pneumol Clin; 2014 Oct; 70(5):298-301. PubMed ID: 24646781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic insufficiency due to antituberculous therapy.
    Liu BA; Knowles SR; Cohen LB; Werb MR; Shear NH
    Ann Pharmacother; 1997 Jun; 31(6):724-6. PubMed ID: 9184712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazinamide-induced granulomatous hepatitis.
    Knobel B; Buyanowsky G; Dan M; Zaidel L
    J Clin Gastroenterol; 1997 Jun; 24(4):264-6. PubMed ID: 9252856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid.
    Durand F; Bernuau J; Pessayre D; Samuel D; Belaiche J; Degott C; Bismuth H; Belghiti J; Erlinger S; Rueff B
    Hepatology; 1995 Apr; 21(4):929-32. PubMed ID: 7705802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
    Jasmer RM; Snyder DC; Saukkonen JJ; Hopewell PC; Bernardo J; King MD; Kawamura LM; Daley CL;
    Clin Infect Dis; 2004 Feb; 38(3):363-9. PubMed ID: 14727206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute liver failure caused by isoniazid in a child receiving carbamazepine.
    Berkowitz FE; Henderson SL; Fajman N; Schoen B; Naughton M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):603-6. PubMed ID: 9661830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent dysosmia induced by pyrazinamide.
    El Aïdli S; Kastalli S; Zaïem A; Lakhoua G; Rejeibi I; Loueslati MH; Daghfous R; Belkahia C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):539-41. PubMed ID: 19674115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy.
    Idilman R; Ersoz S; Coban S; Kumbasar O; Bozkaya H
    Liver Transpl; 2006 Sep; 12(9):1427-30. PubMed ID: 16933231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions observed during DOTS.
    Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
    J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.